Thymidine kinase 1 through the ages: a comprehensive review by Bitter, Eliza E, Townsend, Michelle H, Erickson, Rachel, Allen, Carolyn, O'Neill, Kim L

Get full text

TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells by Bitter, Eliza E, Skidmore, Jonathan, Allen, Carolyn I, Erickson, Rachel I, Morris, Rachel M, Mortimer, Toni, Meade, Audrey, Brog, Rachel, Phares, Tim, Townsend, Michelle, Pickett, Brett E, O'Neill, Kim L

Get full text

Differential placental ceramide levels during gestational diabetes mellitus (GDM) by Mejia, Juan F, Hirschi, Kelsey M, Tsai, Kary Y F, Long, Matthew G, Tullis, Benton C, Bitter, Eliza E K, Bikman, Benjamin T, Reynolds, Paul R, Arroyo, Juan A

Get full text

Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells by Velazquez, Edwin J, Brindley, Taylor D, Shrestha, Gajendra, Bitter, Eliza E, Cress, Jordan D, Townsend, Michelle H, Berges, Bradford K, Robison, Richard A, Weber, K Scott, O'Neill, Kim L

Get full text

Overexpression and surface localization of HPRT in prostate cancer provides a potential target for cancer specific antibody mediated cellular cytotoxicity by Townsend, Michelle H., Bennion, Kelsey B., Bitter, Eliza E., Felsted, Abigail M., Robison, Richard A., O'Neill, Kim L.

Get full text

Abstract 2858: Thymidine kinase 1 variability in primary and metastatic human breast cell lines and its correlation to metastatic potential by Bitter, Eliza E., Townsend, Michelle H., Bennion, Kelsey A., Mejia, Juan, Shrestha, Gajendra, Hirschi, Kelsey, Arroyo, Juan, O'Neill, Kim

Get full text

Abstract 264: Differential expression of HPRT in prostate cancer leads to investigation of its ADCC effects by Townsend, Michelle H., Bennion, Kelsey A., Ence, Zac E., Bitter, Eliza E., Felsted, Abi M., Lattin, John E., Reese, McKay D., Piccolo, Stephen R., O'Neill, Kim L.

Get full text

Abstract 2987: Generation and characterization of a panel of monoclonal antibodies against the tumor biomarker Thymidine Kinase 1 for research, clinical and therapeutic application... by Velazquez, Edwin J., Brindley, Taylor D., Shrestha, Gajendra, Skabelund, Rachel A., Lee, Corbin M., Ewel, Zachary D., Bitter, Eliza E., Townsend, Michelle H., Bennion, Kelsey B., Ong, Kai Li, Whitley, Kiara V., Robison, Richard A., Weber, Scott K., O'Neill, Kim L.

Get full text

Abstract 159: Thymidine kinase 1 and cell cycle control in breast cancer by Bitter, Eliza E., Mortimer, Toni, Morris, Rachel, Barlow, Kai, Schekall, Abby, Townsend, Michelle, Pickett, Brett E., O'Neill, Kim L.

Get full text

Abstract 1322: The potential effects of thymidine kinase 1 on breast cancer invasion by Bitter, Eliza E., Morris, Rachel M., Mortimer, Toni, Barlow, Kai, Schekall, Abigail, Townsend, Michelle H., Skidmore, Jonathan, Pickett, Brett E., O'Neill, Kim L.

Get full text

TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells by Eliza E. Bitter, Jonathan Skidmore, Carolyn I. Allen, Rachel I. Erickson, Rachel M. Morris, Toni Mortimer, Audrey Meade, Rachel Brog, Tim Phares, Michelle Townsend, Brett E. Pickett, Kim L. O’Neill

Get full text